Health Care Weekly Preview from ML Strategies – June 2018 #2

Mintz - Health Care Viewpoints

Welcome to the third week of this four week stretch. This week, the House will continue to vote on a number of proposals to address the opioid crisis. Last week the House passed over 30 bills on opioids, most of which were non-controversial and reached bipartisan support. However, the bills considered this week are expected to have spending tied to it and could be more controversial.

On the Senate side, CREATES and the Preventing Drug Diversion Act of2018 moved out of the Senate Judiciary Committee last week. This advancement puts both pieces in play to be tied to opioids come July. We could likely see the House combine all passed opioid bills into a package and send it to the Senate. The Senate could then add CREATES and the Preventing Drug Diversion Act of 2018, and potentially measures addressing the doughnut hole to the final opioid package. And this could all get done before August. We watch for signals this week to predict how it all plays out.

Please see full Preview below for more information.

LOADING PDF: If there are any problems, click here to download the file.

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Mintz - Health Care Viewpoints | Attorney Advertising

Written by:

Mintz - Health Care Viewpoints

Mintz - Health Care Viewpoints on:

Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
- hide
- hide

This website uses cookies to improve user experience, track anonymous site usage, store authorization tokens and permit sharing on social media networks. By continuing to browse this website you accept the use of cookies. Click here to read more about how we use cookies.